Improving the safety of transfusion therapy.
Enormous strides have been made to reduce the risk of transfusion-transmitted disease. Additional tests to eliminate transfusion-transmitted disease are costly, in terms of both health care resources and availability of volunteer donors. Future improvements in safety probably will require postdraw treatment of blood and components and the use of pharmacologic agents as a substitute for transfusion.